Pseudomonas aeruginosa exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines. Issue 2 (February 2015)

• Record Type: Journal Article
• Authors: Goldufsky, Joe; Wood, Stephen; Hajihossainlou, Behnam; Rehman, Tooba; Majdobeh, Omar; Kaufman, Howard L.; Ruby, Carl E.; Shafikhani, Sasha H.
• Is Part Of: Journal of medical microbiology. Volume 64:Issue 2(2015)
• Publication Date: 2015-02
• Subjects: Medical microbiology -- Periodicals; 616.9041
• DOI: 10.1099/jmm.0.000003-0
• Languages: English
• ISSNs: 0022-2615

Abstract

Abstract : In patients with malignancy, the major barrier to achieving complete response is emergence of resistance to current chemotherapeutic agents. One of the major mechanisms by which tumour cells become resistant to therapies is by altering cellular drug targets through mutations and/or deletions. Resistance by this mechanism is achieved more easily if the drug has limited cellular targets and/or processes. We hypothesized that as Pseudomonas aeruginosa exotoxin T (ExoT) targets six proteins that are required for cancer cell survival and proliferation, it is highly unlikely for cancer cells to develop resistance to this toxin. We assessed ExoT's cytotoxicity against multiple invasive and highly resistant tumour cell lines in order to evaluate its potential as a chemotherapeutic agent. Our data demonstrated that ExoT induced potent cytotoxicity in all tumour cell lines that we examined. Collectively, our data highlighted the potential of ExoT as a possible chemotherapeutic candidate for the treatment of cancer. Abbreviations: EGFR, epidermal growth factor receptor; ExoT, exotoxin T; LDH, lactate dehydrogenase; PI, propidium iodide; T3SS, type III secretion system.